Forwarded from 疫時代🌊Pandemic ᴛʀᴜᴛʜs
研究中的動物發生了什麼?
What happened to the animals in the studies?
這項技術已經在動物身上進行了嘗試,並且在完成的動物研究中,並非所有動物都因注射而立即死亡,而是數月後因其他免疫疾病,敗血症和/或心力衰竭而死亡。從未有使用該技術的長期成功的動物研究。沒有實驗性冠狀病毒疫苗在動物研究中獲得成功。在這項研究中,冠狀病毒疫苗引起了實驗動物的肝臟炎症。
♨️肺
♨️線粒體,紅細胞,白細胞,
肝臟,
♨️免疫系統和神經系統起作用(這可能是在疫苗受害者中看到的貝爾麻痺和震顫的原因。)
This technology has been tried on animals, and in the animal studies done, all the animals died, not immediately from the injection, but months later, from other immune disorders, sepsis and/or cardiac failure. There has never been a long-term successful animal study using this technology. No experimental #coronavirus vaccine has succeeded in animal studies. In this study, coronavirus vaccine caused liver inflammation in #test animals.
♨️Lungs ,
♨️Mitochondria, red blood cells, white blood cells,
♨️Liver,
♨️Immune and nervous systems function (This is the likely cause of the Bell’s Palsy and tremors that are seen in #vaccine victims.)
https://www.primarydoctor.org/covidvaccine
#AnimalTest #動物實驗
轉自友台 奇拿的死亡筆記本
What happened to the animals in the studies?
這項技術已經在動物身上進行了嘗試,並且在完成的動物研究中,並非所有動物都因注射而立即死亡,而是數月後因其他免疫疾病,敗血症和/或心力衰竭而死亡。從未有使用該技術的長期成功的動物研究。沒有實驗性冠狀病毒疫苗在動物研究中獲得成功。在這項研究中,冠狀病毒疫苗引起了實驗動物的肝臟炎症。
♨️肺
♨️線粒體,紅細胞,白細胞,
肝臟,
♨️免疫系統和神經系統起作用(這可能是在疫苗受害者中看到的貝爾麻痺和震顫的原因。)
This technology has been tried on animals, and in the animal studies done, all the animals died, not immediately from the injection, but months later, from other immune disorders, sepsis and/or cardiac failure. There has never been a long-term successful animal study using this technology. No experimental #coronavirus vaccine has succeeded in animal studies. In this study, coronavirus vaccine caused liver inflammation in #test animals.
♨️Lungs ,
♨️Mitochondria, red blood cells, white blood cells,
♨️Liver,
♨️Immune and nervous systems function (This is the likely cause of the Bell’s Palsy and tremors that are seen in #vaccine victims.)
https://www.primarydoctor.org/covidvaccine
#AnimalTest #動物實驗
轉自友台 奇拿的死亡筆記本
primarydoctor
COVID VACCINE Considerations | PrimaryDoctor
Covid vaccine considerations, product package insert, clinical trials, mRNA, antibody dependent enhancement, ADE